Granules India to Deploy Rs 2,000 Crore Across Complex Generics, Oncology and Peptides
Granules India is planning a Rs 2,000 crore investment to drive growth in complex generics, oncology and peptide segments, The Times of India reported on 7 October 2026. No further breakdown of the planned expenditure, timeline or project locations was available from the source headline.
| Detail | Information |
|---|---|
| Promoter | Granules India |
| Planned Investment | Rs 2,000 crore |
| Focus Areas | Complex generics, oncology, peptides |
| Source | The Times of India, 7 October 2026 |
| Stage | Not disclosed |
Granules India's Existing Capital Project Footprint
Projects India already tracks several capital commitments by Granules India across Telangana and Andhra Pradesh. These include a Rs 2,000 crore Active Pharmaceutical Ingredients project at Kakinada, East Godavari, Andhra Pradesh; a Rs 53 crore Bulk Drugs and Active Pharmaceutical Ingredients manufacturing expansion at Bonthapally, Sangareddy, Telangana; a Rs 53 crore Active Pharma Ingredients manufacturing expansion at Bonthapally Village, Medak, Telangana; a Metformin project at Chinnaram, Medak, Telangana (value not recorded); and a Rs 4 crore synthetic organic chemicals project at Bonthapally, Medak, Telangana.
The newly reported Rs 2,000 crore plan appears to be a separate, broader strategic commitment; however, no sub-project locations or site-level details were available in the reported headline.
Context: Petroleum Products and Refinery Projects Tracked Nationally
While Granules India operates in pharmaceuticals, Projects India notes that the broader Petroleum Products [Refinery] sub-sector — under which this story is classified in our database — currently has 123 live tracked projects nationally, with one added in the last 90 days. There are no open India tenders in the Mining Projects sector at this time.
Among the largest active tracked projects in the refinery sub-sector is the Bharat Petroleum Corporation Limited Refinery and Petrochemical Complex at SPSR Nellore, Andhra Pradesh, valued at Rs 103,408 crore and currently under approvals. Indian Oil Corporation Limited's petroleum refinery expansion at Koyali, Vadodara, Gujarat, valued at Rs 17,825 crore, has entered the construction stage. Readers can view the full Mining Projects sector overview for further detail.
Where Refinery and Petroleum Projects Are Concentrated
The stage and geography breakdown of the 123 tracked projects in this sub-sector offers a practical map for suppliers and contractors assessing where activity is densest. By state, Gujarat leads with 17 tracked projects, followed by Maharashtra (15), Andhra Pradesh (14), Assam (12), Tamil Nadu (10) and Odisha (9).
By project stage, the pipeline is heavily weighted towards early-cycle opportunity: 53 projects are under approvals, 33 have started construction, 21 are in planning, 4 are nearly complete, 2 have received approvals, and 8 are completed. The under-approvals cohort of 53 projects represents the largest near-term pipeline for vendors tracking contract opportunities ahead of final investment decisions.
What this means for suppliers and contractors
For suppliers operating in active pharmaceutical ingredients, oncology formulations or peptide chemistry, Granules India's stated Rs 2,000 crore strategic intent signals a meaningful scale-up in procurement demand across specialised raw materials, process equipment and engineering services. The company already has a documented track record of capital deployment across Telangana and Andhra Pradesh, making those states a logical starting point for vendors seeking early engagement.
For contractors and equipment makers active in the broader refinery and petroleum products space, the stage data is instructive: with 53 projects currently under approvals nationally, a significant wave of construction-stage contracts is likely to emerge over the coming quarters, particularly in Gujarat, Maharashtra and Andhra Pradesh where project counts are highest. Vendors are advised to track the full pipeline of tracked projects and monitor live tenders as approvals convert to active procurement across both sectors.
Frequently asked questions
How much is Granules India investing in its expansion plan?
Granules India is planning a Rs 2,000 crore investment to drive growth in complex generics, oncology and peptide segments, as reported by The Times of India on 7 October 2026. No further breakdown of the expenditure or timeline was available from the source.
What segments is Granules India targeting with its Rs 2,000 crore investment?
According to The Times of India, Granules India is targeting complex generics, oncology and peptide segments with the planned Rs 2,000 crore investment. No additional detail on specific product lines or facility locations was available from the source headline.
Where does Granules India currently have capital projects underway?
Projects India tracks Granules India projects in Telangana and Andhra Pradesh, including a Rs 2,000 crore Active Pharmaceutical Ingredients project at Kakinada and multiple expansions at Bonthapally, with a combined tracked value exceeding Rs 2,100 crore across recorded projects.
